Why TPAs Are Taking Ownership of the Pharmacy Benefit
July 10, 2026
As employers demand more transparency, better cost control, and a more connected benefits experience, third party administrators (TPAs) have an opportunity to play a larger role in pharmacy.
For many self-funded employers, pharmacy has moved from a line item to a boardroom-level concern. Costs are rising, specialty drugs are creating new risk, and brokers are asking harder questions about transparency, PBM rebates, and data access.
That puts TPAs in a difficult position. They are often the first call when an employer wants answers, but the pharmacy benefit may still sit with a separate PBM partner that controls key parts of the economics, reporting, and member experience.
That gap is creating a new opportunity.
TPAs are starting to take more ownership of the pharmacy benefit, not necessarily by becoming a full PBM overnight, but by building or private-labeling PBM capabilities that give them real control and flexibility over margin, data, and clinical strategy.
Here are 6 reasons more TPAs are considering that move:
1. Employers are asking harder pharmacy questions
Employers are no longer satisfied with high-level pharmacy reports or broad assurances about savings. They want to understand what they are paying for, where dollars are going, and which levers can actually change the outcome.
That creates pressure for TPAs.
When the PBM sits outside the TPA relationship, the TPA may be expected to answer questions it doesn’t fully control. By taking more ownership of the pharmacy model, TPAs can give employer clients a clearer view of pharmacy spend, rebate strategy, utilization trends, and plan performance.
2. Pharmacy can shift from administrative burden to growth strategy
Many TPAs are already doing the work around pharmacy: coordinating eligibility, fielding questions, supporting reporting requests, and helping employers make sense of PBM-related issues. But in many cases, they are not compensated for the complexity they are absorbing.
Owning more of the pharmacy benefit changes the business model. Instead of treating pharmacy as a pass-through vendor relationship, TPAs can create a private-label solution that supports employer clients, strengthens broker relationships, and opens a new revenue stream tied to pharmacy benefit administration.
3. Medical and pharmacy data are more powerful together
The real value isn’t just in pharmacy claims data; it’s in what happens when pharmacy and medical data can be viewed together.
For TPAs, that combined view can support better utilization management, stronger clinical programs, earlier identification of risk, and more informed conversations with employers. It also creates a foundation for more advanced work, including predictive modeling and targeted interventions.
When pharmacy remains disconnected from the rest of the plan administration ecosystem, those insights are harder to access and harder to act on.
4. TPAs can bring brokers and employers a more differentiated story
In a crowded TPA market, cost-containment solutions are becoming part of the differentiation conversation. Brokers and employers want partners who can do more than administer claims. They want partners who can help connect the pieces, explain the strategy, and identify where better decisions can lower cost or improve outcomes.
A TPA with a private-label PBM solution has a different story to tell: one accountable partner, better data continuity, and more flexibility to design around the client’s needs.
5. Formulary and clinical strategy become more flexible
Formulary decisions have a major impact on pharmacy cost, member experience, and clinical outcomes. But TPAs often have limited influence over those decisions when pharmacy is managed entirely outside their model.
With more ownership of the pharmacy benefit, TPAs can help align formulary, utilization management, clinical programs, and reporting to the needs of their employer clients and the populations they serve.
6. Stop-loss and high-cost drug reporting can become more coordinated
High-cost specialty drugs can create downstream issues for employers, TPAs, and stop-loss partners. When pharmacy data arrives late, lacks detail, or sits outside the rest of the claims picture, it can slow reporting and make reimbursement conversations harder than they need to be.
Bringing pharmacy data closer to the TPA’s existing workflows can improve coordination around high-cost claims, specialty drug management, accumulators, and reporting. For employer clients, that can mean fewer surprises and a more defensible view of what is driving cost.
The big picture: transparency is becoming the expectation
The market has already started moving. Employers want transparency, brokers are asking harder questions, and PBM reform is drawing closer regulatory attention than ever. The TPAs that own their pharmacy benefit are going to have better answers than the ones that don't.
But, taking ownership of pharmacy doesn't mean building every PBM function from scratch. RxSense has already done that work. We built RxIQ® Enterprise, assembled a proven ecosystem of solutions, and created the operational infrastructure to support you end-to-end.
For many TPAs we work with, the right path is a staged approach: start with a private-label solution that gives you immediate visibility and control and then you can begin to leverage pharmacy as a differentiator for new business as you continue to learn and grow.
Curious what this could look like for your TPA?